Canadian Sec - Delayed Quote CAD

MariMed Inc. (MRMD.CN)

0.1000

0.0000

(0.00%)

At close: June 13 at 2:29:03 PM EDT

MariMed’s Premium Nature’s Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDose

All-Natural Line of Wellness Products Designed to Support Overall Well-Being Now Available in MassachusettsNORWOOD, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), the company behind the award-winning flower and concentrate brand, Nature’s Heritage™, continued to drive innovation with the launch of MycroDose by Nature’s Heritage, a vegan line of all-natural wellness products that combine the power of full-spectrum cannabis with the added benefits of fu

GlobeNewswire 17 days ago

MRMD
MariMed Inc (MRMD) Q1 2025 Earnings Call Highlights: Strategic Expansion Amidst Market Challenges

Despite flat overall revenue and increased net loss, MariMed Inc (MRMD) showcases growth in wholesale revenue and strategic market expansion initiatives.

GuruFocus.com last month

MRMD
MariMed Inc. (MRMD) Reports Q1 Loss, Lags Revenue Estimates

MariMed Inc. (MRMD) delivered earnings and revenue surprises of 0% and 0.97%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

MRMD
MariMed Reports First Quarter 2025 Earnings

NORWOOD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2025. Management Commentary “We are executing on our vision to build the best consumer packaged goods company in cannabis, and over the past quarter we continued to penetrate more storefronts and capture more market share for ou

GlobeNewswire last month

MRMD
MariMed Announces First Quarter 2025 Earnings Date

NORWOOD, Mass., April 08, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report first quarter 2025 financial results on May 7, 2025 after the markets close. Management will host a conference call on May 8, 2025 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q125 Earni

GlobeNewswire 2 months ago

MRMD
MariMed Promotes Ryan Crandall to Chief Commercial Officer

NORWOOD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Mr. Crandall will lead the Company’s commercial strategy and activities, including Sales, Marketing, Product Development, and Retail Operations. He has served as MariMed’s Chief Revenue Officer since July 2022, and prior was

GlobeNewswire 2 months ago

MRMD
MariMed’s Betty’s Eddies Expands Top-Selling Brand With Introduction of THC & CBG-Infused Caramel Chews

Each Betty’s Caramelt Away Chew Uses Rich, Buttery Caramel, To Create Moments of MellowNORWOOD, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Betty’s Eddies™, the all-natural cannabis chews handcrafted to fit a variety of needs, is expanding its lineup with the introduction of delicious caramel chews: Betty’s Caramelt Away. Betty’s Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX:

GlobeNewswire 2 months ago

MRMD
MariMed Launches Nature’s Heritage™ Flower in Illinois

NORWOOD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, has officially introduced its Nature’s Heritage™-branded cannabis flower, pre-rolls, and vapes in Illinois. This marks the first time the brand’s premium products are available in the state. The launch follows the late 2024 openning of MariMed’s Mt. Vernon, Illinois, cultivation facility. Nature’s Heritage products ar

GlobeNewswire 2 months ago

MRMD
MariMed Inc (MRMD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion ...

Despite a challenging retail environment, MariMed Inc (MRMD) achieves record full-year revenue and significant wholesale growth, while focusing on strategic market expansions.

GuruFocus.com 3 months ago

MRMD
MariMed Reports Fourth Quarter and Full Year 2024 Earnings

NORWOOD, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the fourth quarter and year ended December 31, 2024. MariMed CEO Jon Levine commented, “We’re pleased to report record revenues and improved adjusted EBITDA for MariMed. I continue to believe we own one of the strongest portfolios of cannabis brands in the ind

GlobeNewswire 3 months ago

MRMD
MariMed Completes Acquisition of First State Compassion, Strengthening Market Position in Delaware

NORWOOD, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, announced today it has completed its acquisition of First State Compassion Center (“FSCC”), the leading cannabis operator in Delaware, in accordance with the terms of the previously announced Omnibus Agreement entered into with FSCC in July 2023. The acquisition integrates FSCC’s cultivation and processing facilities, and two dispensari

GlobeNewswire 3 months ago

MRMD
MariMed Announces Fourth Quarter and Full Year 2024 Earnings Date

NORWOOD, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced today it will report fourth quarter and full year 2024 financial results on March 5, 2025 after the markets close. Management will host a conference call on March 6, 2024, at 8:00 a.m. EST to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor R

GlobeNewswire 4 months ago

MRMD
MariMed Commences Wholesale Operations in Missouri

NORWOOD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, announces the launch of cannabis wholesale operations in Missouri. MariMed’s award-winning products are now available in select dispensaries across the state. “Expanding our branded products into Missouri has been a key goal for us,” said Ryan Crandall, Chief Revenue Officer. “Missouri’s fast-growing market is eager for high-quality produ

GlobeNewswire 5 months ago

MRMD
MariMed Inc (MRMD) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Industry Challenges

Despite macroeconomic headwinds, MariMed Inc (MRMD) reports revenue growth and strategic expansion, with a focus on brand development and M&A opportunities.

GuruFocus.com 7 months ago

MRMD
MariMed Reports Third Quarter 2024 Earnings

NORWOOD, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the third quarter ended September 30, 2024. “We reported year-over-year and sequential revenue growth, sequential EBITDA and Net Income improvement, and we continue to generate positive operating cash flow,” said Jon Levine, Chief Executive Officer. “Our wholes

GlobeNewswire 7 months ago

MRMD
InHouse by MariMed Launches Help on the Homefront, to Support Veterans Facing Housing Challenges

Local Veterans in Maryland, Massachusetts, Delaware, and Illinois Can Enter to Win $5,000 to Help Offset the Cost of Housing or Home Improvements this NovemberNORWOOD, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- InHouse™, MariMed’s (“MariMed”) (CSE: MRMD) (OTCQX: MRMD) high quality, value-priced line of flower, vapes, and gummies, is committed to serving local communities by finding ways to provide support to those in need. The mission continues this November with the brand’s latest philanthropic i

GlobeNewswire 7 months ago

MRMD
MariMed Commences Manufacturing Operations in Missouri

NORWOOD, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, announced the start of cannabis product manufacturing in Missouri. MariMed’s award-winning products are expected to be available across the state in time for the holidays. “Expanding our branded products into Missouri has been a key goal for us,” said Ryan Crandall, Chief Revenue Officer. “Missouri’s fast-growing market is eager for high-

GlobeNewswire 7 months ago

MRMD
MariMed Commences Cultivation Operations in Mt. Vernon, Illinois Grow Facility

Seedlings Planted In Time for Retail and Wholesale Distribution in Early 2025NORWOOD, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, today announced it commenced operations in its new cultivation facility in Mt. Vernon, Illinois. The first harvest is expected in early 2025, at which time the Company will sell its award-winning Nature’s Heritage flower and concentrates through its retail and whol

GlobeNewswire 7 months ago

MRMD
MariMed Inc (MRMD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid Margin Pressures

Despite robust revenue increases, MariMed Inc (MRMD) faces challenges with declining margins and cash reserves.

GuruFocus.com 8 months ago

MRMD
MariMed Announces Third Quarter 2024 Earnings Date

NORWOOD, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced today it will report third quarter 2024 financial results on November 6, 2024 after the markets close. Management will host a conference call on November 7, 2024 at 8:00 a.m. EST to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations w

GlobeNewswire 8 months ago

MRMD

Performance Overview

Return	MRMD.CN	S&P 500 (^GSPC)
YTD	-33.33%	+1.62%
1-Year	-56.52%	+10.00%
3-Year	-88.89%	+59.40%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

MariMed Inc. (MRMD.CN)

MariMed’s Premium Nature’s Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDose

MariMed Inc (MRMD) Q1 2025 Earnings Call Highlights: Strategic Expansion Amidst Market Challenges

MariMed Inc. (MRMD) Reports Q1 Loss, Lags Revenue Estimates

MariMed Reports First Quarter 2025 Earnings

MariMed Announces First Quarter 2025 Earnings Date

MariMed Promotes Ryan Crandall to Chief Commercial Officer

MariMed’s Betty’s Eddies Expands Top-Selling Brand With Introduction of THC & CBG-Infused Caramel Chews

MariMed Launches Nature’s Heritage™ Flower in Illinois

MariMed Inc (MRMD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion ...

MariMed Reports Fourth Quarter and Full Year 2024 Earnings

MariMed Completes Acquisition of First State Compassion, Strengthening Market Position in Delaware

MariMed Announces Fourth Quarter and Full Year 2024 Earnings Date

MariMed Commences Wholesale Operations in Missouri

MariMed Inc (MRMD) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Industry Challenges

MariMed Reports Third Quarter 2024 Earnings

InHouse by MariMed Launches Help on the Homefront, to Support Veterans Facing Housing Challenges

MariMed Commences Manufacturing Operations in Missouri

MariMed Commences Cultivation Operations in Mt. Vernon, Illinois Grow Facility

MariMed Inc (MRMD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid Margin Pressures

MariMed Announces Third Quarter 2024 Earnings Date

Performance Overview